InvestorsHub Logo
Followers 9
Posts 920
Boards Moderated 0
Alias Born 04/21/2014

Re: None

Saturday, 12/09/2017 11:18:56 PM

Saturday, December 09, 2017 11:18:56 PM

Post# of 37495
OMHE_has_(1)R&D_Biotech_Lab_(2)Scientists_(3)MMJ_License_(4)Developed_Cannabinoid_based_Medicine

Status, as of Nov 2017

(1) Specialty Pharmaceuticals –----------------- Completed - Click here to see proof
(2) Anti-Aging Brands –---------------------------- Completed - Click here to see proof
(3) Therapeutic Cannabis Products –---------- Completed - Click here to see proof
(4) Licensed Medical Marijuana Cultivation – INPROGRESS – WILL BE ANNOUNCED SOON

Most of the R&D companies are in their initial stages of Cannabinoid_based Therapy & Medicine development. OMHE's researchers are best among all and OMHE's work is in advanced (final) stages.

Link To The News

I am delighted to report that we reached the end of a long process that began over ten months ago, culminating in the several high-profile developments we will soon be announcing. There have been extensive negotiations that we have not talked about publicly, but as we are now in the final stages of these negotiations, we can now speak more openly about two important developments that will bring the Company to a completely new level of success.

The first, which we can share now, is development in the sphere of a cannabinoid-based drug-development. In collaboration with Dr. Karyemaitre Aliffe, MD, Omni Health is finalizing a regulatory path to commercialization of a breakthrough, proprietary compound agent with the potential to treat chronic pain.





OMHE PPS is rising to $1


Made Thousands into Millions..Now in Tens of Millions